BICLUSTER_ID : DNREG-42
PATHOGENS /3/ : pseudomonas aeruginosa,bifidobacterium bifidum,lactobacillus acidophilus
TARGETS /40/ : POLA1, PFAS, NDUFA5, MGST3, NARS, GART, TARS, IARS2, AURKA, FKBP4, YARS, NDUFB5, ADSL, NDUFS1, BLVRA, SDHC, NDUFA6, PET112L, GARS, WEE1, NDUFS2, MCM6, CDK2, DHFR, IMPDH2, PAICS, MTHFD1, HPRT1, PPIC, RRM1, ATIC, ATP1A1, NDUFA9, ME2, PARP1, SLC25A5, IDH1, PPAT, IARS, DARS
Gene SetLeading Edge Genes
ACEVEDO LIVER TUMOR VS NORMAL ADJACENT TISSUE UPSET, MAGOH, CETN2, ELOVL6, MGST3, IARS2, AURKA, PRPSAP1, PEA15, HTATSF1, NCBP2, RBM34, NDUFB5, BLVRA, PTPN12, SDHC, CKS1B, DOCK1, SMARCC1, ACTL6A, WRB, PDIA6, CCT8, MRPS18B, CKS2, DDX46, CNIH, SSR1, NUP205, RANBP6, ARL2BP, MAPKAPK3, MLH1, HPRT1, EIF2A, RBBP7, ATP2A2, PPIC, GNPAT, RFC4, SERTAD2, RPA3, PIGB, SMC3, SLC9A6, NHP2L1, CCT2, MSH6, PARP1, IDH1, DRG1, MDC1, ZMPSTE24, PEX19, PPAT, GMFB, RPA1, ACLY, PSME3, EEF1E1, RCN2, NRD1, DEGS1
CREIGHTON ENDOCRINE THERAPY RESISTANCE 1IMPDH2, PAICS, MTHFD1, ARL3, FKBP4, ATIC, PA2G4, ADSL, CENPF, SFXN3, CCNB2, PARP1, UNG, FTO, TGIF2, SNRPD2, ANP32B, CDK2, HUWE1, RBMX
MOOTHA VOXPHOSNDUFA6, NDUFA9, PET112L, ATP5I, ATP5C1, ATP5G1, NDUFA5, NDUFS2, ATP5H, UQCRC2, NDUFB5, NDUFS1, CYC1, SDHC
REACTOME ELECTRON TRANSPORT CHAINNDUFA6, NDUFA9, NDUFA5, NDUFS2, NDUFB5, UQCRC2, NDUFS1, CYC1, SDHC
REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESISATIC, IMPDH2, PPAT, ADSL, PAICS, PFAS, GART
REACTOME CYTOSOLIC TRNA AMINOACYLATIONYARS, GARS, EEF1E1, IARS, DARS, NARS, TARS
NCI CYTOSOLIC TRNA AMINOACYLATIONYARS, GARS, EEF1E1, IARS, DARS, NARS, TARS
NCI DE NOVO SYNTHESIS OF IMPATIC, ADSL, PAICS, PPAT, PFAS, GART
GRADE COLON AND RECTAL CANCER UPSET, MTHFD1, GTF3A, CCNB1, TARS, RAN, MRPL3, RRM1, ATIC, PA2G4, PTPN12, RFC5, DDX1, GARS, KIF23, CCT5, DHX9, MDC1, MELK, NPM1
REACTOME G1 S TRANSITIONCKS1B, POLA1, DHFR, POLE2, ORC2L, WEE1, CCNB1, DBF4, MCM6, E2F2, CDK2
CHIANG LIVER CANCER SUBCLASS UNANNOTATED DNMAD2L1, RAN, ATIC, RFC4, PRPS1, RPA3, ATP1A1, RFC5, DBI, CCNB2, CCT2, MSH2, PDIA6, ME2, SLC25A5, POLE2, RAD51AP1, CCT4, RNASEH2A, SNRPD2, SLC39A6, NUP205, RCN2, LSM2
RHODES UNDIFFERENTIATED CANCERCKS1B, GARS, MAD2L1, KIF23, CCNB1, CENPA, MCM6, MELK, RFC4, TOP2A, TRIP13
REACTOME CYCLIN A1 ASSOCIATED EVENTS DURING G2 M TRANSITIONCCNB2, CDC25C, CCNB1, WEE1
SCIBETTA KDM5B TARGETS DNBUB1B, NCAPH, TTK, IVNS1ABP, CCNB1, SMARCA2, ARL6IP5, AURKA, PSME3, PRPS1, TOP2A, BUB3, PLS3
KAUFFMANN DNA REPAIR GENESATR, MAD2L1, XRCC1, TOP2B, MLH1, CETN3, HUS1, RRM1, RFC4, RPA3, TOP2A, TOPBP1, RFC5, MLH3, MSH6, MSH2, UNG, POLE2, PMS1, RAD51AP1, GTF2H1, SSRP1, FANCL, RPA1, CHEK2
CORUM DNA SYNTHESOME COMPLEX 17 SUBUNITSPOLA1, RPA1, TOP2B, TOP2A, POLE2, PRIM1
GALE APL WITH FLT3 MUTATED UP
REACTOME MITOCHONDRIAL TRNA AMINOACYLATION
CORUM KU ANTIGEN-YY1-ALPHAMYHC PROMOTER COMPLEX
KEGG FATTY ACID METABOLISM
NCI NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY
BOYAULT LIVER CANCER SUBCLASS G123 UP
DANG BOUND BY MYC
CORUM BRAFT COMPLEX
KUMAMOTO RESPONSE TO NUTLIN 3A DN
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
CORUM NCOA6-DNA-PK-KU-PARP1 COMPLEX
OUELLET OVARIAN CANCER INVASIVE VS LMP UP
SANA RESPONSE TO IFNG DN
SLEBOS HEAD AND NECK CANCER WITH HPV UP
CORUM C COMPLEX SPLICEOSOME
REACTOME PEROXISOMAL LIPID METABOLISM
CORUM F1F0-ATP SYNTHASE EC 3.6.3.14 MITOCHONDRIAL
MOREAUX B LYMPHOCYTE MATURATION BY TACI DN
NCI REPAIR SYNTHESIS FOR GAP FILLING BY DNA POLYMERASE IN TC NER
WONG MITOCHONDRIA GENE MODULE
CORUM CCT MICRO-COMPLEX
CORUM 6S METHYLTRANSFERASE AND RG-CONTAINING SM PROTEINS COMPLEX
NCI AR PATHWAY
RODRIGUES THYROID CARCINOMA ANAPLASTIC UP
CORUM PCNA-MSH2-MSH6 COMPLEX
LINDGREN BLADDER CANCER WITH LOH IN CHR9Q
NCI CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION
CORUM CHECKPOINT RAD COMPLEX
REACTOME CHOLESTEROL BIOSYNTHESIS
BOYAULT LIVER CANCER SUBCLASS G23 UP
CORUM P400-ASSOCIATED COMPLEX
PUJANA BREAST CANCER LIT INT NETWORK
KEGG MISMATCH REPAIR
STARK PREFRONTAL CORTEX 22Q11 DELETION DN
CORUM DNA SYNTHESOME COMPLEX 13 SUBUNITS
WELCSH BRCA1 TARGETS 1 UP
PUIFFE INVASION INHIBITED BY ASCITES UP
NCI MITOTIC METAPHASE ANAPHASE TRANSITION
REACTOME APCDC20 MEDIATED DEGRADATION OF CYCLIN B
SENESE HDAC3 TARGETS DN
REACTOME SYNTHESIS OF DNA
CORUM EXOSOME
VALK AML CLUSTER 15
PYEON CANCER HEAD AND NECK VS CERVICAL UP
CORUM BASC AB 80 COMPLEX BRCA1-ASSOCIATED GENOME SURVEILLANCE COMPLEX
REACTOME CITRIC ACID CYCLE
CORUM BASC COMPLEX BRCA1-ASSOCIATED GENOME SURVEILLANCE COMPLEX
MORI EMU MYC LYMPHOMA BY ONSET TIME UP
CORUM TOPOSOME
KEGG STEROID BIOSYNTHESIS
LIN MELANOMA COPY NUMBER UP
CORUM NUCLEAR PORE COMPLEX
KEGG PEROXISOME
CORUM 17S U2 SNRNPSNRPE, DDX46, SF3B3, HSPD1, SNRPD2, DHX15
YANG BREAST CANCER ESR1 LASER DN
CORUM TIP49-TIP48-BAF53 COMPLEX
CORUM 18S U11/U12 SNRNP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 13
KEGG OXIDATIVE PHOSPHORYLATION
SPIRA SMOKERS LUNG CANCER DN
WAKASUGI HAVE ZNF143 BINDING SITES
CAFFAREL RESPONSE TO THC 24HR 5 UP
NCI COOPERATION OF PREFOLDIN AND TRIC CCT IN ACTIN AND TUBULIN FOLDING
LASTOWSKA NEUROBLASTOMA COPY NUMBER DN
CORUM KU-ORC COMPLEX
GARY CD5 TARGETS DN
BENPORATH NANOG TARGETS
BIOCARTA PTC1 PATHWAY
CORUM TIP60 HISTONE ACETYLASE COMPLEX
GOLDRATH HOMEOSTATIC PROLIFERATION
ZHONG RESPONSE TO AZACITIDINE AND TSA DN
REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION
BLALOCK ALZHEIMERS DISEASE DN
NCI CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION
MOHANKUMAR TLX1 TARGETS UP
NCI INACTIVATION OF APC C VIA DIRECT INHIBITION OF THE APC C COMPLEX
NUYTTEN NIPP1 TARGETS DN
KIM WT1 TARGETS DN
ACEVEDO LIVER CANCER UP
CORUM CONDENSIN I-PARP-1-XRCC1 COMPLEX
NCI CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY
PODAR RESPONSE TO ADAPHOSTIN DN
REACTOME PHOSPHORYLATION OF THE APC
KEGG NUCLEOTIDE EXCISION REPAIR
BENPORATH MYC MAX TARGETS
NCI CITRIC ACID CYCLE TCA CYCLE
SEIDEN MET SIGNALING
JIANG HYPOXIA CANCER
REACTOME CELL CYCLE CHECKPOINTS
BHATTACHARYA EMBRYONIC STEM CELL
CORUM C-MYC-ATPASE-HELICASE COMPLEX
ZHAN MULTIPLE MYELOMA SUBGROUPS
NCI PHOSPHORYLATION OF THE APC C
STEIN ESRRA TARGETS
BASSO B LYMPHOCYTE NETWORK
NCI TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM
NCI ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX
WAESCH ANAPHASE PROMOTING COMPLEX
CORUM CMYC-ATPASE-HELICASE COMPLEX
NCI APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS
HAHTOLA MYCOSIS FUNGOIDES CD4 DN
ONKEN UVEAL MELANOMA UP
SASAKI ADULT T CELL LEUKEMIA
ZHANG RESPONSE TO IKK INHIBITOR AND TNF DN
CORUM DMAP1-ASSOCIATED COMPLEX
NCI PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC
NCI CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
MANN RESPONSE TO AMIFOSTINE DN
REACTOME INACTIVATION OF APC VIA DIRECT INHIBITION OF THE APCOMPLEX
WATANABE RECTAL CANCER RADIOTHERAPY RESPONSIVE UP
NCI TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA
JEON SMAD6 TARGETS DN
MARTINEZ RESPONSE TO TRABECTEDIN DN
NCI REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
BIOCARTA RB PATHWAY
REACTOME DNA REPLICATION PRE INITIATION
REACTOME TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY
GEORGES TARGETS OF MIR192 AND MIR215
CORUM MSH2-MSH6-PMS1-MLH1 COMPLEX
NCI TRANSFORMATION OF LANOSTEROL TO CHOLESTEROL
NAKAMURA TUMOR ZONE PERIPHERAL VS CENTRAL UP
SU TESTIS
RAMALHO STEMNESS UP
DING LUNG CANCER EXPRESSION BY COPY NUMBER
NCI FOLDING OF ACTIN BY CCT TRIC
KEGG PARKINSONS DISEASE
NAKAMURA LUNG CANCER MARKERS
LEE LIVER CANCER SURVIVAL DN
KEGG OOCYTE MEIOSIS
NCI APC CDC20 MEDIATED DEGRADATION OF NEK2A
KEGG PROPANOATE METABOLISM
STEIN ESRRA TARGETS UP
NCI CHAPERONIN MEDIATED PROTEIN FOLDING
LEE METASTASIS AND RNA PROCESSING UP
HU ANGIOGENESIS DN
RICKMAN TUMOR DIFFERENTIATED WELL VS POORLY UP
NCI PROPIONYL COA CATABOLISM
NCI E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION
RICKMAN METASTASIS UP
WEST ADRENOCORTICAL TUMOR UP
BROWNE HCMV INFECTION 10HR DN
CORUM PCNA-MUTS-ALPHA-MUTL-ALPHA-DNA COMPLEX
SHAFFER IRF4 TARGETS IN ACTIVATED B LYMPHOCYTE
CORUM MULTISYNTHETASE COMPLEX
JAATINEN HEMATOPOIETIC STEM CELL UP
NAKAMURA LUNG CANCER
CAFFAREL RESPONSE TO THC 24HR 5 DN
NCI MITOCHONDRIAL TRNA AMINOACYLATION
FAELT B CLL WITH VH REARRANGEMENTS DN
MOREAUX MULTIPLE MYELOMA BY TACI DN
OUELLET CULTURED OVARIAN CANCER INVASIVE VS LMP UP
RHODES CANCER META SIGNATURE
NCI FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC
NCI FORMATION OF ATP BY CHEMIOSMOTIC COUPLING
CORUM RAD17-RFC-9-1-1 CHECKPOINT SUPERCOMPLEX
CORUM E2F-6 COMPLEX
FLECHNER PBL KIDNEY TRANSPLANT OK VS DONOR UP
KEGG PROGESTERONE MEDIATED OOCYTE MATURATION
Color legend
q-value-1-0.2-0.05-0.01-0.001-0.0001
Color
TABLE OF Q-VALUES
lactobacillus acidophilusbifidobacterium bifidumpseudomonas aeruginosaGeneSet Name
-0.00129 -0.00072 -0.01279ACEVEDO_LIVER_TUMOR_VS_NORMAL_ADJACENT_TISSUE_UP
-0.00206 -0.00061 -0.02408CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1
-0.00010 -0.00001 -0.07540MOOTHA_VOXPHOS
-0.00013 -0.00015 -0.07078REACTOME_ELECTRON_TRANSPORT_CHAIN
-0.00014 -0.00003 -0.03954REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS
-0.00074 -0.00027 -0.00732REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION
-0.00110 -0.00011 -0.00429NCI_CYTOSOLIC_TRNA_AMINOACYLATION
-0.00182 -0.00116 -0.09371NCI_DE_NOVO_SYNTHESIS_OF_IMP
-0.00043 -0.00003 -0.07257GRADE_COLON_AND_RECTAL_CANCER_UP
-0.00092 -0.00002 -0.05329REACTOME_G1_S_TRANSITION
-0.00561 -0.00019 -0.00006CHIANG_LIVER_CANCER_SUBCLASS_UNANNOTATED_DN
-0.00080 -0.00003 -0.02924RHODES_UNDIFFERENTIATED_CANCER
-0.00020 -0.00001 -0.03396REACTOME_CYCLIN_A1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
-0.00009 -0.00001 -0.02302SCIBETTA_KDM5B_TARGETS_DN
-0.00009 -0.00001 -0.04560KAUFFMANN_DNA_REPAIR_GENES
-0.00058 -0.00005 -0.07338CORUM_DNA_SYNTHESOME_COMPLEX_17_SUBUNITS
-0.11685 -0.01930 -0.02995GALE_APL_WITH_FLT3_MUTATED_UP
-0.00562 -0.01168 -0.09753REACTOME_MITOCHONDRIAL_TRNA_AMINOACYLATION
-0.15380 -0.16293 -0.17689CORUM_KU_ANTIGEN-YY1-ALPHAMYHC_PROMOTER_COMPLEX
-0.11590 -0.15893 -0.10258KEGG_FATTY_ACID_METABOLISM
-0.03515 -0.00181 -0.13817NCI_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
-0.09604 -0.05508 -0.01718BOYAULT_LIVER_CANCER_SUBCLASS_G123_UP
-0.01007 -0.01502 -0.17910DANG_BOUND_BY_MYC
-0.10790 -0.00947 -0.07528CORUM_BRAFT_COMPLEX
-0.00892 -0.02902 -0.07193KUMAMOTO_RESPONSE_TO_NUTLIN_3A_DN
-0.12158 -0.00726 -0.08242THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
-0.03559 -0.06094 -0.15892CORUM_NCOA6-DNA-PK-KU-PARP1_COMPLEX
-0.17661 -0.05713 -0.00029OUELLET_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
-0.00201 -0.02951 -0.01466SANA_RESPONSE_TO_IFNG_DN
-0.07168 -0.00395 -0.02942SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP
-0.00009 -0.00007 -0.15911CORUM_C_COMPLEX_SPLICEOSOME
-0.00884 -0.10805 -0.07680REACTOME_PEROXISOMAL_LIPID_METABOLISM
-0.07899 -0.00390 -0.02675CORUM_F1F0-ATP_SYNTHASE_EC_3.6.3.14_MITOCHONDRIAL
-0.03986 -0.00212 -0.07235MOREAUX_B_LYMPHOCYTE_MATURATION_BY_TACI_DN
-0.00254 -0.00006 -0.18027NCI_REPAIR_SYNTHESIS_FOR_GAP_FILLING_BY_DNA_POLYMERASE_IN_TC_NER
-0.00183 -0.00930 -0.08070WONG_MITOCHONDRIA_GENE_MODULE
-0.01416 -0.00932 -0.13616CORUM_CCT_MICRO-COMPLEX
-0.08384 -0.07732 -0.12914CORUM_6S_METHYLTRANSFERASE_AND_RG-CONTAINING_SM_PROTEINS_COMPLEX
-0.04542 -0.11182 -0.03771NCI_AR_PATHWAY
-0.00988 -0.00232 -0.16016RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP
-0.11290 -0.04482 -0.18484CORUM_PCNA-MSH2-MSH6_COMPLEX
-0.04342 -0.01401 -0.07790LINDGREN_BLADDER_CANCER_WITH_LOH_IN_CHR9Q
-0.01573 -0.00695 -0.14694NCI_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION
-0.08450 -0.10392 -0.09560CORUM_CHECKPOINT_RAD_COMPLEX
-0.00604 -0.06933 -0.18726REACTOME_CHOLESTEROL_BIOSYNTHESIS
-0.00067 -0.00003 -0.17995BOYAULT_LIVER_CANCER_SUBCLASS_G23_UP
-0.15185 -0.07634 -0.16088CORUM_P400-ASSOCIATED_COMPLEX
-0.00257 -0.00001 -0.19807PUJANA_BREAST_CANCER_LIT_INT_NETWORK
-0.00004 -0.00001 -0.13621KEGG_MISMATCH_REPAIR
-0.00020 -0.00785 -0.02880STARK_PREFRONTAL_CORTEX_22Q11_DELETION_DN
-0.00268 -0.00025 -0.19900CORUM_DNA_SYNTHESOME_COMPLEX_13_SUBUNITS
-0.19359 -0.10702 -0.00404WELCSH_BRCA1_TARGETS_1_UP
-0.15776 -0.05731 -0.16886PUIFFE_INVASION_INHIBITED_BY_ASCITES_UP
-0.13503 -0.05452 -0.12423NCI_MITOTIC_METAPHASE_ANAPHASE_TRANSITION
-0.14447 -0.02318 -0.03678REACTOME_APCDC20_MEDIATED_DEGRADATION_OF_CYCLIN_B
-0.14624 -0.07778 -0.14639SENESE_HDAC3_TARGETS_DN
-0.03098 -0.00140 -0.12476REACTOME_SYNTHESIS_OF_DNA
-0.00867 -0.01337 -0.14658CORUM_EXOSOME
-0.07647 -0.11384 -0.09034VALK_AML_CLUSTER_15
-0.02499 -0.00013 -0.11840PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP
-0.06130 -0.00810 -0.04581CORUM_BASC_AB_80_COMPLEX_BRCA1-ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX
-0.00100 -0.00019 -0.10992REACTOME_CITRIC_ACID_CYCLE
-0.05382 -0.00218 -0.09605CORUM_BASC_COMPLEX_BRCA1-ASSOCIATED_GENOME_SURVEILLANCE_COMPLEX
-0.02388 -0.00150 -0.04215MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP
-0.04381 -0.02242 -0.18030CORUM_TOPOSOME
-0.00194 -0.14834 -0.12908KEGG_STEROID_BIOSYNTHESIS
-0.08529 -0.00741 -0.18000LIN_MELANOMA_COPY_NUMBER_UP
-0.06643 -0.00811 -0.05340CORUM_NUCLEAR_PORE_COMPLEX
-0.10237 -0.17256 -0.17007KEGG_PEROXISOME
-0.00020 -0.00006 -0.03714CORUM_17S_U2_SNRNP
-0.05068 -0.14470 -0.19670YANG_BREAST_CANCER_ESR1_LASER_DN
-0.08952 -0.12083 -0.10363CORUM_TIP49-TIP48-BAF53_COMPLEX
-0.00096 -0.03082 -0.14234CORUM_18S_U11/U12_SNRNP
-0.00617 -0.01617 -0.15890YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_13
-0.02616 -0.00289 -0.04935KEGG_OXIDATIVE_PHOSPHORYLATION
-0.00990 -0.02848 -0.13040SPIRA_SMOKERS_LUNG_CANCER_DN
-0.00168 -0.00163 -0.19894WAKASUGI_HAVE_ZNF143_BINDING_SITES
-0.02056 -0.01695 -0.14486CAFFAREL_RESPONSE_TO_THC_24HR_5_UP
-0.01317 -0.00770 -0.12248NCI_COOPERATION_OF_PREFOLDIN_AND_TRIC_CCT__IN_ACTIN_AND_TUBULIN_FOLDING
-0.11023 -0.16280 -0.11040LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN
-0.09380 -0.14888 -0.14811CORUM_KU-ORC_COMPLEX
-0.00608 -0.00390 -0.01258GARY_CD5_TARGETS_DN
-0.13814 -0.09682 -0.03969BENPORATH_NANOG_TARGETS
-0.05026 -0.02482 -0.10980BIOCARTA_PTC1_PATHWAY
-0.15595 -0.11481 -0.08885CORUM_TIP60_HISTONE_ACETYLASE_COMPLEX
-0.00229 -0.00101 -0.18933GOLDRATH_HOMEOSTATIC_PROLIFERATION
-0.01392 -0.00057 -0.10608ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN
-0.02385 -0.12386 -0.10948REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION
-0.08398 -0.08101 -0.00026BLALOCK_ALZHEIMERS_DISEASE_DN
-0.08551 -0.02272 -0.18371NCI_CYCLIN_E_ASSOCIATED_EVENTS_DURING_G1_S_TRANSITION_
-0.03991 -0.01367 -0.02157MOHANKUMAR_TLX1_TARGETS_UP
-0.04969 -0.02067 -0.01356NCI_INACTIVATION_OF_APC_C_VIA_DIRECT_INHIBITION_OF_THE_APC_C_COMPLEX
-0.04825 -0.03076 -0.13346NUYTTEN_NIPP1_TARGETS_DN
-0.02088 -0.01291 -0.00054KIM_WT1_TARGETS_DN
-0.13640 -0.09489 -0.00067ACEVEDO_LIVER_CANCER_UP
-0.01173 -0.01619 -0.10103CORUM_CONDENSIN_I-PARP-1-XRCC1_COMPLEX
-0.09467 -0.02733 -0.18050NCI_CYCLIN_A_CDK2_ASSOCIATED_EVENTS_AT_S_PHASE_ENTRY
-0.12288 -0.06699 -0.06152PODAR_RESPONSE_TO_ADAPHOSTIN_DN
-0.16735 -0.02560 -0.09563REACTOME_PHOSPHORYLATION_OF_THE_APC
-0.00448 -0.00238 -0.03758KEGG_NUCLEOTIDE_EXCISION_REPAIR
-0.01279 -0.01077 -0.08688BENPORATH_MYC_MAX_TARGETS
-0.01423 -0.00447 -0.08092NCI_CITRIC_ACID_CYCLE__TCA_CYCLE_
-0.17063 -0.19425 -0.03042SEIDEN_MET_SIGNALING
-0.09610 -0.01818 -0.02512JIANG_HYPOXIA_CANCER
-0.00613 -0.00026 -0.00423REACTOME_CELL_CYCLE_CHECKPOINTS
-0.04152 -0.05096 -0.03178BHATTACHARYA_EMBRYONIC_STEM_CELL
-0.04942 -0.06489 -0.11631CORUM_C-MYC-ATPASE-HELICASE_COMPLEX
-0.00541 -0.00071 -0.19470ZHAN_MULTIPLE_MYELOMA_SUBGROUPS
-0.15065 -0.02484 -0.09607NCI_PHOSPHORYLATION_OF_THE_APC_C
-0.00110 -0.00423 -0.08662STEIN_ESRRA_TARGETS
-0.00401 -0.00224 -0.16721BASSO_B_LYMPHOCYTE_NETWORK
-0.03208 -0.00211 -0.17677NCI_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM
-0.16720 -0.10055 -0.15812NCI_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX
-0.19798 -0.05837 -0.04714WAESCH_ANAPHASE_PROMOTING_COMPLEX
-0.05000 -0.06696 -0.11183CORUM_CMYC-ATPASE-HELICASE_COMPLEX
-0.11114 -0.04166 -0.02050NCI_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS
-0.04832 -0.00667 -0.02319HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN
-0.12498 -0.04838 -0.18667ONKEN_UVEAL_MELANOMA_UP
-0.12943 -0.02669 -0.09321SASAKI_ADULT_T_CELL_LEUKEMIA
-0.01251 -0.01469 -0.04466ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN
-0.18303 -0.09515 -0.15796CORUM_DMAP1-ASSOCIATED_COMPLEX
-0.01049 -0.02246 -0.09104NCI_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE__TO_CCT_TRIC
-0.11267 -0.02436 -0.10992NCI_CHK1_CHK2_CDS1__MEDIATED_INACTIVATION_OF_CYCLIN_B_CDK1_COMPLEX
-0.08618 -0.00556 -0.02813REACTOME_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
-0.09436 -0.00958 -0.14582MANN_RESPONSE_TO_AMIFOSTINE_DN
-0.04943 -0.02271 -0.01134REACTOME_INACTIVATION_OF_APC_VIA_DIRECT_INHIBITION_OF_THE_APCOMPLEX
-0.01877 -0.05114 -0.02736WATANABE_RECTAL_CANCER_RADIOTHERAPY_RESPONSIVE_UP
-0.01760 -0.00119 -0.14653NCI_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA
-0.00003 -0.00006 -0.13834JEON_SMAD6_TARGETS_DN
-0.00324 -0.00352 -0.00098MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN
-0.02258 -0.00242 -0.01943NCI_REGULATION_OF_APC_C_ACTIVATORS_BETWEEN_G1_S_AND_EARLY_ANAPHASE
-0.00525 -0.00054 -0.11360BIOCARTA_RB_PATHWAY
-0.01571 -0.00189 -0.08852REACTOME_DNA_REPLICATION_PRE_INITIATION
-0.00068 -0.00352 -0.14211REACTOME_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.01202 -0.00023 -0.16627REACTOME_NEP_NS2_INTERACTS_WITH_THE_CELLULAR_EXPORT_MACHINERY
-0.10556 -0.03758 -0.01016GEORGES_TARGETS_OF_MIR192_AND_MIR215
-0.09589 -0.04543 -0.11201CORUM_MSH2-MSH6-PMS1-MLH1_COMPLEX
-0.00124 -0.00385 -0.12550NCI_TRANSFORMATION_OF_LANOSTEROL_TO_CHOLESTEROL
-0.00268 -0.00407 -0.15840NAKAMURA_TUMOR_ZONE_PERIPHERAL_VS_CENTRAL_UP
-0.00018 -0.00008 -0.14282SU_TESTIS
-0.00058 -0.00314 -0.00090RAMALHO_STEMNESS_UP
-0.19751 -0.07736 -0.00113DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER
-0.01495 -0.01159 -0.12921NCI_FOLDING_OF_ACTIN_BY_CCT_TRIC
-0.06903 -0.01713 -0.04469KEGG_PARKINSONS_DISEASE
-0.14921 -0.07043 -0.11871NAKAMURA_LUNG_CANCER_MARKERS
-0.00627 -0.00053 -0.00284LEE_LIVER_CANCER_SURVIVAL_DN
-0.05740 -0.00459 -0.00045KEGG_OOCYTE_MEIOSIS
-0.05067 -0.01357 -0.01596NCI_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A
-0.02277 -0.09374 -0.03223KEGG_PROPANOATE_METABOLISM
-0.00073 -0.00248 -0.06554STEIN_ESRRA_TARGETS_UP
-0.01146 -0.00815 -0.12159NCI_CHAPERONIN_MEDIATED_PROTEIN_FOLDING
-0.03756 -0.04261 -0.04421LEE_METASTASIS_AND_RNA_PROCESSING_UP
-0.01528 -0.04881 -0.00006HU_ANGIOGENESIS_DN
-0.06171 -0.02139 -0.00868RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP
-0.05507 -0.12295 -0.19479NCI_PROPIONYL_COA_CATABOLISM
-0.03972 -0.19704 -0.10132NCI_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION
-0.02371 -0.06510 -0.00225RICKMAN_METASTASIS_UP
-0.00173 -0.00673 -0.01510WEST_ADRENOCORTICAL_TUMOR_UP
-0.14880 -0.19359 -0.00860BROWNE_HCMV_INFECTION_10HR_DN
-0.01566 -0.01510 -0.13369CORUM_PCNA-MUTS-ALPHA-MUTL-ALPHA-DNA_COMPLEX
-0.02615 -0.02003 -0.09445SHAFFER_IRF4_TARGETS_IN_ACTIVATED_B_LYMPHOCYTE
-0.01897 -0.03490 -0.04214CORUM_MULTISYNTHETASE_COMPLEX
-0.11556 -0.07951 -0.00898JAATINEN_HEMATOPOIETIC_STEM_CELL_UP
-0.14614 -0.07155 -0.10500NAKAMURA_LUNG_CANCER
-0.03453 -0.01724 -0.03826CAFFAREL_RESPONSE_TO_THC_24HR_5_DN
-0.00491 -0.01068 -0.08043NCI_MITOCHONDRIAL_TRNA_AMINOACYLATION
-0.11692 -0.13671 -0.01766FAELT_B_CLL_WITH_VH_REARRANGEMENTS_DN
-0.01167 -0.00105 -0.01021MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN
-0.05717 -0.15117 -0.14610OUELLET_CULTURED_OVARIAN_CANCER_INVASIVE_VS_LMP_UP
-0.03156 -0.00528 -0.02762RHODES_CANCER_META_SIGNATURE
-0.01041 -0.00909 -0.13118NCI_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC
-0.08124 -0.00693 -0.02984NCI_FORMATION_OF_ATP_BY_CHEMIOSMOTIC_COUPLING
-0.08205 -0.10810 -0.09584CORUM_RAD17-RFC-9-1-1_CHECKPOINT_SUPERCOMPLEX
-0.07457 -0.05442 -0.18337CORUM_E2F-6_COMPLEX
-0.16450 -0.17773 -0.11671FLECHNER_PBL_KIDNEY_TRANSPLANT_OK_VS_DONOR_UP
-0.13731 -0.02276 -0.13358KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION